Point72 Asset Management, L.P. 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:24 pm Sale | 2026-03-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Point72 Asset Management, L.P. | 2,136,940 4.200% | -644,962 (-23.18%) | Filing |
| 2026-01-13 6:03 pm Purchase | 2026-01-05 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Point72 Asset Management, L.P. | 2,781,902 5.500% | 258,409 (+10.24%) | Filing |
| 2026-01-12 6:34 pm Purchase | 2026-01-05 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Point72 Asset Management, L.P. | 2,523,493 4.900% | 2,523,493 (New Position) | Filing |